the identified miRNA in 112 colorectal tumor samples from the patients. We identified 12 possible miRNAs involved in 5-FU resistance by miRNA arrays. We then examined the relationship between miR-31, which was the most promising among them, and drug resistance. The ectopic expression of mimic miR-31 showed signifi- 
K E Y W O R D S
5-fluorouracil, colorectal cancer, drug resistance, microRNA, Warburg effect genomic aberrations are closely associated with carcinogenesis. 7, 8 Recent increasing evidence shows that the expression of miRNA genes is deregulated in human cancers. 7, 8 Previously, we reported that the dysregulation of miRNA-143, -145, -7, -34a and -21 might have affected the endoscopic appearance and development pathways of colorectal tumors. 9, 10 Moreover, we reported that the miR-143 showed a significant tumor-suppressive effect of DLD-1 human colorectal cancer cells in vitro and in vivo through silencing KRAS signaling networks. 9, 11, 12 Currently, many anti-cancer drugs have been developed and used for metastatic and adjuvant treatment of colorectal cancer. 13 fluorouracil (5-FU) 14 is one of the most popular and important anticancer drugs for colorectal cancer in the world. 13 Therefore, the drug resistance of 5-FU makes treatment with systemic chemotherapy difficult in colorectal cancer. It is reported that dysregulation of microRNA expression causes drug resistance in colorectal cancer. [15] [16] [17] [18] [19] In the current study, we established 4 types of 5-FU-resistant colon cancer cell lines in in vitro and in vivo mouse models. We analyzed the miRNA expression profile by miRNA array and found the predictive 5-FU resistance-related miRNAs. Among them, we concluded that miR-31 is closely involved in 5-FU resistance in colorectal cancer cells. 
| MATERIAL S AND ME THODS

| Reagents
| Cell culture and cell viability
Human colorectal malignant cell lines DLD-1 and SW480 were grown in RPMI-1640 medium supplemented with 10% (v/v) heatinactivated FBS (Sigma) and 2 mmol/L L-glutamine under an atmosphere of 95% air and 5% CO 2 at 37°C. Other cell lines, such as SW480 (KRAS-mutated), WiDr (BRAF-mutated), HT-29 (BRAF-mutated) and SW48 (both wild) cells, were also used. The evaluation of cell growth was determined by trypan blue (FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan) dye-exclusion assay. For evaluating IC 50 , the starting cell number was 1 × 10 5 /mL.
| Establishing 5-fluorouracil-resistant colon cancer cell lines in vitro and in vivo
We establish 5-FU-resistant colon cancer cell lines in vitro. First, we sowed DLD-1 or SW480 cells in a culture bottle and exposed the cells to a low dose 5-FU (half dose of IC 50 ). 5-FU was diluted with DMSO. We repeatedly gradually exposed 5-FU in low to high doses to DLD-1 or SW480 cells, and were able to establish DLD/F (5-FUresistant DLD-1) and SW/F (5-FU-resistant SW480).
At the same time, we establish 5-FU-resistant colon cancer cell lines in an in vivo mouse model. 
| Cell cycle distribution
Quantification of cell cycle distribution was determined by using FACS. 20 Briefly, the cells were harvested and fixed with 70% cold 
| Patients and tissue preparation
All human samples were obtained in a fresh state from patients who had undergone a direct biopsy for diagnosis or surgery for resection of colorectal tumors at Fujita Health University Hospital proteins. We examined the identified miRNA expression levels in 112 sporadic colorectal polyps (7 hyperplastic polyps and 14 serrated adenomas).
| RNA isolation and quantitative real-time PCR
Total RNA was isolated from the tissues using TRIzol containing phenol/guanidium isothiocyanate and treatment with DNase I.
9-
11 At first, expression levels of miRNAs <0.50 were designated as downregulated and >2.00 as upregulated through estimating microRNA array estimation (Human miRNA Oligo chip, TORAY, Tokyo, Japan).
After that, to examine the expression levels of miRNAs in detail, we performed TaqMan MicroRNA Assays using a real-time PCR apparatus (Life Technologies, Grand Island, NY, USA). [9] [10] [11] [22] [23] [24] We examined the expression levels of tumor miRNAs compared with those of the paired normal samples in a blinded fashion. The threshold cycle (Ct) is defined as the fractional cycle number at which the fluorescence passes a fixed threshold. The range of Ct values of these miRNAs in colorectal cancer was from 18 to 40. In our data, we judged that there was no miRNA expression over 28 cycles, because there were miRNA molecules less than 50 copies per 1 mL in Ct value 28. The levels of miRNAs in each tissue were measured and normalized to those of U6, which was used as an internal control. [9] [10] [11] 24 The relative expression levels were calculated using the ΔΔCt method. The relative expression level in normal tissue was indicated as "1."
In human samples, the tumor/non-tumor ratio of each miRNA expression in the samples was determined. The tumor/non-tumor ratio of each miRNA expression in the samples was expressed using box-and-whisker plots.
| Transfection experiments
DLD-1 and DLD/F cells were seeded in 6-well plates at a concentra- Fisher's extract test, or single-factor ANOVA for differences between 2 groups. A P-value of 0.05 was considered significant. All calculations were performed by using software BellCurve for Excel (version 2; SSRI).
| Statistics and data analysis
| RE SULTS
We were able to establish 5-FU-resistant colon cancer cell lines in in vitro and in vivo mouse models. We named DLD/F cells, Figure 3A ).
In contrast, anti-miR-31 caused significant growth inhibition in DLD/F cells ( Figure 3B ). When we exposed a high dose of 5-FU to parent or 5-FU-resitant cells, the expression levels of miR-31 were raised higher than those of control cells (Figure 4 ).
We determined that one of the important target genes related to chemoresistance of miR-31 was FHI-1 (http://micro rna.sanger.
ac.uk/). FIH-1 is also known as hypoxia inducible factor 1 alpha subunit inhibitor (HIF1AN). It has already been reported that miR-31
inhibited the expression of FIH-1. 28, 29 In addition, FIH-1 inhibited 20 We examined the expression of FIH-1 protein after transfection of the mimic miR-31 into the parent cells by western blot analysis ( Figure 5A ). The expression levels of FIH-1 protein were markedly decreased and PKM1 protein was increased by transfection with mimic miR-31 in parent cells. We also examined the expression of FIH-1 protein after transfection of the anti-miR-31
into the 5-FU-resistant cells ( Figure 5B ). The expression levels of FIH-1 protein were increased by transfection with anti-miR-31
in 5-FU-resistant cells. In addition, silencing FIH-1 increased the resistance to 5-FU in SW48 (KRAS wild) and DLD-1 (KRAS mutant) cells ( Figure 5C ).
Finally, we analyzed the expression level of miR-31 in colorectal tumor tissues and compared this with that of adjacent normal colon tissues in the same patient. The expression level in each tumor sample was evaluated using the relative ratio of tumor to non-tumor tissue.
The expression level of miR-31 was lower in adenoma or early cancer depth mucosa than early cancer depth submucosa or advanced cancer ( Figure 6 ). Expression levels of >10.0 were considered upregulated. The expression levels of miR-31 in adenoma and carcinoma in situ were significantly lower than those of carcinomas invading submucosa and advanced cancers (Table 1 ). The expression level of miR-31was positively associated with the grade of the clinical stage of colorectal tumors.
| D ISCUSS I ON
Various regimens were developed with the aim of more effective treatment for metastatic and adjuvant treatment of colorectal cancer. 13 For example, 5-FU/leucovorin, 30-32 FOLFOX (5-FU, leucovorin and oxaliplatin) [33] [34] [35] or FOLFIRI (5-FU, leucovorin and irinotecan) [34] [35] [36] [37] FOLFOXILI (5-FU, leucovorin, oxaliplatin and irinotecan) [35] [36] [37] are well-known regimens globally. 5-FU is one of most important anticancer drugs for treatment of colorectal adenocarcinoma. 13 Drug resistance of anticancer drugs makes treatment with systemic chemotherapy difficult. Many studies have reported on the mechanisms of drug resistance. 38 Recently, it has become clear that microRNA plays an important role in drug resistance for chemotherapy of cancer. 18, 19 We previously reported that miR-34a or miR-145 was related to drug resistance in colorectal cancer, too. [15] [16] [17] In this study, we suggested that miR-31 was related to the 5-FU resistance in colorectal cancer. There are some reports that miR-31 is related to the 5-FU resistance in colorectal cancer. The Warburg effect is a well-known feature of cancer cell metabolism. 41 In addition, it is well known that there are many factors that establish the Warburg effect (eg, HIF-1 and c-Myc). 42 We previously reported the relationship between drug resistance and the Warburg effect. 20, 43 Hypoxia-inducible factor 1α (HIF-1α) is an important protein to maintain the Warburg effect, because HIF-1α mediated transcriptional responses to localized hypoxia in normal tissues and in cancers and can promote tumor progression by altering cellular metabolism and stimulating angiogenesis. 44 There were some reports F I G U R E 6 Box-and-whisker plots of miRNA-31 expression in colorectal tumors. The relative expression levels were calculated using the ΔΔCt method, with RNU6B used as a control. The relative expression levels were calculated using the ΔΔCt method, with RNU6B used as a control. The relative expression level in normal tissue was indicated as "1." The expression levels in tumors were designated as upregulated when the fold change from the expression in the non-tumorous tissue was 10.0. Statistical differences in miRNA levels were evaluated by using Pearson's χ 2 test and, Fisher's exact test for differences between 2 groups. A P-value of 0.05 was considered to be significant; statistical analysis was done in this manner for all subsequent tables. M, carcinoma in situ; SM, carcinoma invades submucosa.
concerning the relationship between drug resistance and HIF-1.
45-47 FIH-1 inhibited HIF-1α activity. FIH-1 protein inhibited PKM-1. 20 Moreover, there were some reports that miR-31 targeted FIH and enhanced the Warburg effect. 26, 27, 48 In our data, the protein expression levels of FIH-1 were decreased markedly; in contrast, those of PKM-1 were increased by the transfection with mimic miR-31 in DLD-1 cells ( Figure 5 ). Moreover, the growth ability of 5-FU-resistant cells was lower than that of control cells ( Figure 1A ). Our data suggested that the protein expression of CDK4 and Cyclin B1 was lower in 5-FU cells than parent cells ( Figure 1C ). There was likely inhibition of transition from G1 to S1 phase in 5-FU-resistant cells.
Furthermore, the expression level of miR-31 was higher in early cancer invading submucosa or advanced cancer than carcinoma in situ or adenoma ( Figure 6 and Table 1 ). These data might suggest that upregulated miR-31 expression caused 5-FU resistance in colorectal cancer through maintenance of the Warburg effect ( Figure S1 ).
The serrated neoplastic pathway came with the discovery that mutations in the oncogene BRAF occur in serrated polyps. 49, 50 In addition, high miR-31 expression was significantly associated with BRAF mutation in colorectal cancers. 50 We examined the expression levels of miR-31 in serrated adenomas and hyperplastic polyps. The expression level of miR-31 was higher in serrated adenomas than hyperplastic polyps (P = 0.078; Table S1 ). It was certain that BRAF 
